COMMUNIQUÉS West-GlobeNewswire
-
Trading by management and close relations of management
02/09/2024 - 18:36 -
Nyxoah Sonne la Cloche de Clôture sur le Nasdaq alors qu'elle se Prépare à Lancer sa Technologie Innovante pour l'Apnée du Sommeil sur le Marché Américain
02/09/2024 - 22:05 -
Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device
02/09/2024 - 22:05 -
Cytokinetics Presents Additional Data From SEQUOIA-HCM at the European Society of Cardiology Congress 2024
01/09/2024 - 09:51 -
Cytokinetics Presents New Data Related to the Safety and Long-Term Use of Aficamten at the European Society of Cardiology Congress 2024
01/09/2024 - 10:27 -
Belite Bio Announces Appointment of Hendrik P. N. Scholl, MD, MA, as Chief Medical Officer
01/09/2024 - 14:00 -
Avricore Grants Options
31/08/2024 - 03:29 -
Junshi Biosciences Announces 2024 Interim Financial Results and Provides Corporate Updates
31/08/2024 - 05:56 -
George Medicines demonstrates potential of novel, low-dose, triple combination pill to transform management of hypertension in Hot Line Session at ESC Congress 2024
31/08/2024 - 09:54 -
Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
30/08/2024 - 01:32 -
Raw Garden Announces End of Summer and Labor Day Deals
30/08/2024 - 02:50 -
HUTCHMED Provides Update on Fruquintinib for Second-Line Gastric Cancer in China
30/08/2024 - 06:30 -
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
30/08/2024 - 10:39 -
BioConnection appoints Dr. Gary M. Phillips as new Chairman of its Supervisory Board
30/08/2024 - 10:43 -
Trading by management and close relations of management
30/08/2024 - 12:17 -
Psyence Biomed Announces Registration Statement on Form F-1 for Up to $25 Million Equity Line of Credit with White Lion Capital, LLC, Declared Effective by SEC
30/08/2024 - 13:00 -
Passage Bio to Present at H.C. Wainwright 26th Annual Global Investment Conference
30/08/2024 - 13:00 -
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2024
30/08/2024 - 13:00 -
Opthea Reports Full-Year Financial Results and Business Updates
30/08/2024 - 13:30
Pages